ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 238 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q1 2021. The put-call ratio across all filers is 2.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $473 | +4.2% | 35,978 | 0.0% | 0.01% | +25.0% |
| Q2 2023 | $454 | +2.3% | 35,978 | +5.7% | 0.00% | 0.0% |
| Q1 2023 | $444 | -26.0% | 34,032 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $600 | -99.9% | 34,032 | -19.1% | 0.01% | -25.0% |
| Q3 2022 | $641,000 | -33.2% | 42,092 | -1.2% | 0.01% | -11.1% |
| Q1 2022 | $959,000 | +22.0% | 42,590 | 0.0% | 0.01% | +28.6% |
| Q4 2021 | $786,000 | +38.1% | 42,590 | 0.0% | 0.01% | +40.0% |
| Q3 2021 | $569,000 | -27.8% | 42,590 | 0.0% | 0.01% | -28.6% |
| Q2 2021 | $788,000 | +23.3% | 42,590 | 0.0% | 0.01% | +16.7% |
| Q1 2021 | $639,000 | +14.7% | 42,590 | +10.4% | 0.01% | 0.0% |
| Q4 2020 | $557,000 | +132.1% | 38,590 | +30.9% | 0.01% | +100.0% |
| Q3 2020 | $240,000 | +27.0% | 29,476 | +5.5% | 0.00% | +50.0% |
| Q2 2020 | $189,000 | +11.8% | 27,946 | +16.7% | 0.00% | 0.0% |
| Q1 2020 | $169,000 | -28.1% | 23,946 | 0.0% | 0.00% | -33.3% |
| Q4 2019 | $235,000 | -10.6% | 23,946 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $263,000 | -17.6% | 23,946 | -12.8% | 0.00% | -25.0% |
| Q2 2019 | $319,000 | +21.8% | 27,446 | 0.0% | 0.00% | +33.3% |
| Q1 2019 | $262,000 | -10.6% | 27,446 | -9.6% | 0.00% | -25.0% |
| Q4 2018 | $293,000 | -32.2% | 30,346 | 0.0% | 0.00% | -20.0% |
| Q3 2018 | $432,000 | +10.2% | 30,346 | -7.0% | 0.01% | 0.0% |
| Q2 2018 | $392,000 | -2.7% | 32,646 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $403,000 | -20.5% | 32,646 | -6.2% | 0.01% | -16.7% |
| Q4 2017 | $507,000 | +2.4% | 34,820 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $495,000 | +11.5% | 34,820 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $444,000 | -7.5% | 34,820 | -7.9% | 0.01% | 0.0% |
| Q1 2017 | $480,000 | +4.6% | 37,820 | -16.0% | 0.01% | 0.0% |
| Q4 2016 | $459,000 | -13.6% | 45,000 | +11.7% | 0.01% | -14.3% |
| Q3 2016 | $531,000 | +3.7% | 40,300 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $512,000 | -3.8% | 40,300 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $532,000 | +7.5% | 40,300 | +25.2% | 0.01% | +16.7% |
| Q4 2015 | $495,000 | +24.1% | 32,200 | 0.0% | 0.01% | +20.0% |
| Q3 2015 | $399,000 | -9.3% | 32,200 | 0.0% | 0.01% | 0.0% |
| Q2 2015 | $440,000 | +14.3% | 32,200 | 0.0% | 0.01% | +25.0% |
| Q1 2015 | $385,000 | -6.3% | 32,200 | 0.0% | 0.00% | -20.0% |
| Q4 2014 | $411,000 | -4.9% | 32,200 | 0.0% | 0.01% | 0.0% |
| Q3 2014 | $432,000 | -16.4% | 32,200 | 0.0% | 0.01% | -16.7% |
| Q2 2014 | $517,000 | -82.2% | 32,200 | -80.0% | 0.01% | -82.4% |
| Q1 2014 | $2,902,000 | -23.0% | 160,950 | -33.9% | 0.03% | -22.7% |
| Q4 2013 | $3,767,000 | -8.5% | 243,650 | -12.0% | 0.04% | +15.8% |
| Q3 2013 | $4,116,000 | +13.4% | 276,790 | -1.3% | 0.04% | +11.8% |
| Q2 2013 | $3,629,000 | – | 280,430 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kent Lake Capital LLC | 925,000 | $12,154,500 | 4.67% |
| EVR Research LP | 1,289,037 | $16,937,946 | 4.48% |
| Tamarack Advisers, LP | 435,000 | $5,715,900 | 3.70% |
| KESTREL INVESTMENT MANAGEMENT CORP | 263,900 | $3,468 | 2.19% |
| Tamarack Advisers, LP | 200,000 | $2,628,000 | 1.70% |
| Numerai GP LLC | 274,319 | $3,604,552 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 525,915 | $6,910,523 | 0.86% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 585,254 | $7,690,238 | 0.23% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 2,401,754 | $31,559,048 | 0.22% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,543,242 | $33,418,194 | 0.19% |